COc1cc2c(cc1OC)-c1cc(Nc3cccc(F)c3)nc(=O)n1CC2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?